Hankins Jane, Naidu Paula, Rieman Martha, Wang Winfred, Kaushansky Kenneth, Rodriguez-Galindo Carlos
Department of Hematology-Oncology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
J Pediatr Hematol Oncol. 2004 Feb;26(2):142-5. doi: 10.1097/00043426-200402000-00019.
Patients with essential thrombocythemia (ET) usually have normal thrombopoietin (TPO) concentrations because of negative feedback from thrombocytosis. TPO mutations in familial ET cases result in increased translation efficiency with excessive TPO stimulation and thrombocytosis. The authors describe an infant with a high platelet count (1300 x 103/mm3) and an elevated TPO concentration who was successfully treated with anagrelide. Sequencing of TPO revealed no genetic cause. This case may represent a case of atypical ET in which thrombocytosis results from TPO stimulation rather than clonal proliferation. Measuring TPO concentrations may be warranted for children with unexplained extreme thrombocytosis.
原发性血小板增多症(ET)患者由于血小板增多的负反馈作用,其血小板生成素(TPO)浓度通常正常。家族性ET病例中的TPO突变导致翻译效率增加,伴有TPO过度刺激和血小板增多。作者描述了一名血小板计数高(1300×10³/mm³)且TPO浓度升高的婴儿,该婴儿接受阿那格雷治疗成功。TPO测序未发现遗传原因。该病例可能代表非典型ET,其中血小板增多是由TPO刺激而非克隆增殖引起的。对于不明原因的极度血小板增多症患儿,可能有必要检测TPO浓度。